Cynthia Colllins

Cynthia Collins was appointed chief executive officer in January 2017. Before joining Human Longevity, she was chief executive officer and general manager of GE Healthcare's In Vitro Diagnostics, Research & Applied Markets, and Cell Therapy from October 2013 to December 2016